<?xml version="1.0" encoding="UTF-8"?>
<p>Ambroxol (trans-4-[[(2-amino-3,5-dibromophenyl)methyl] amino]cyclohexanolhydrochlo-ride) also deserves attention as an additional antiviral agent (Yang 
 <italic>et al</italic>. 
 <xref rid="bib306" ref-type="bibr">2002</xref>). The 
 <italic>in vitro</italic> inhibitory effects of ambroxol on influenza virus were described in 2014 (Yamaya 
 <italic>et al</italic>. 
 <xref rid="bib304" ref-type="bibr">2014</xref>). The spectrum of pharmacological activity of ambroxol, in addition to its mucolytic effects (Rogers 
 <xref rid="bib227" ref-type="bibr">2007</xref>), includes antibacterial and anti-biofilm effects (Lu 
 <italic>et al</italic>. 
 <xref rid="bib164" ref-type="bibr">2010</xref>; Li 
 <italic>et al</italic>. 
 <xref rid="bib153" ref-type="bibr">2011</xref>; Cabral-Romero 
 <italic>et al</italic>. 
 <xref rid="bib36" ref-type="bibr">2013</xref>; Cataldi 
 <italic>et al</italic>. 
 <xref rid="bib44" ref-type="bibr">2014</xref>); the ability to serve as chemical chaperones (Bendikov-Bar 
 <italic>et al</italic>. 
 <xref rid="bib18" ref-type="bibr">2013</xref>; Sanchez-Martinez 
 <italic>et al</italic>. 
 <xref rid="bib231" ref-type="bibr">2016</xref>), modulate surfactant secretion (Yang 
 <italic>et al</italic>. 
 <xref rid="bib306" ref-type="bibr">2002</xref>; Seifart 
 <italic>et al</italic>. 
 <xref rid="bib237" ref-type="bibr">2005</xref>), provide anti-inflammatory (Gibbs 
 <italic>et al</italic>. 
 <xref rid="bib88" ref-type="bibr">1999</xref>; Beeh 
 <italic>et al</italic>. 
 <xref rid="bib15" ref-type="bibr">2008</xref>; Gupta 
 <xref rid="bib94" ref-type="bibr">2010</xref>) and antioxidant action (Nowak 
 <italic>et al</italic>. 
 <xref rid="bib196" ref-type="bibr">1994</xref>; Stetinová, Herout and Kvetina 
 <xref rid="bib265" ref-type="bibr">2004</xref>); and the ability to locally (in the respiratory airways) stimulate the secretion of IgA and IgG (Yang 
 <italic>et al</italic>. 
 <xref rid="bib306" ref-type="bibr">2002</xref>) as well as to provide a local anesthetic effect (Kern and Weiser 
 <xref rid="bib132" ref-type="bibr">2015</xref>). Due to these diverse effects and high oral bioavailability (Jauch 
 <italic>et al</italic>. 
 <xref rid="bib119" ref-type="bibr">1978</xref>), ambroxol may be included in a list of medications used for the treatment of viral pneumonias.
</p>
